Pediatric Radiation Therapy Registry for Sarcoma and Brain Tumors

This registry is collecting information from pediatric patients (ages 0-26) who receive either proton or photon radiation therapy for sarcoma or pediatric brain tumors. The goal is to understand the long-term effects and side effects (toxicity) of these treatments. Researchers will look at how long patients live (Overall Survival) and the number of side effects over about 10 years. This study is observational, meaning you won't receive a new treatment, but your existing treatment information will be collected to help improve care for future patients. The study aims to include 5000 participants, but its current recruitment status is unclear.

Study design
This is an observational study, meaning it collects information without assigning new treatments. It plans to include up to 5000 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for approximately 10 years to assess overall survival and toxicity.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07129317

Pediatric Radiation Therapy Registry

Recruiting
Not specifiedAges 0–26Observational
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
~5,000 participants
Updated 2025-11-05 on ClinicalTrials.gov

At a glance

Recruiting sites
2 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Overall Survival
Measured over Approximately 10 years
+1 more outcome measured
Sarcoma
Pediatric Brain Tumors
2 sites across 2 states
District of Columbia1
Maryland1
  • Sahaja Acharya, MD · PRINCIPAL_INVESTIGATOR · SKCCC Johns Hopkins Medical Institution

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Treatment with either proton or photon radiation therapy.

Exclusion

Greater than 26 years old
  • Overall SurvivalApproximately 10 years

    Measured from date of diagnosis until death, obtained from medical record notes

  • Toxicity due to Radiation Therapy as assessed by number of patients with adverse eventsApproximately 10 years

    The number of patients that experience adverse events, obtained from medical record notes